20,000 Shares in Stericycle, Inc. (NASDAQ:SRCL) Bought by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Stericycle, Inc. (NASDAQ:SRCL) during the 2nd quarter, Holdings Channel.com reports. The firm acquired 20,000 shares of the business services provider’s stock, valued at approximately $1,163,000.

Several other hedge funds have also added to or reduced their stakes in SRCL. Clearstead Trust LLC acquired a new stake in Stericycle during the 1st quarter worth $25,000. GAMMA Investing LLC raised its stake in Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after buying an additional 516 shares during the period. TFO Wealth Partners LLC raised its stake in Stericycle by 22,325.0% during the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after buying an additional 893 shares during the period. Headlands Technologies LLC acquired a new stake in Stericycle during the 1st quarter worth $44,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of Stericycle in the 2nd quarter valued at about $45,000. Institutional investors and hedge funds own 98.82% of the company’s stock.

Stericycle Stock Performance

Shares of NASDAQ:SRCL opened at $61.68 on Tuesday. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $61.77. The stock has a market cap of $5.73 billion, a PE ratio of -280.36, a P/E/G ratio of 3.37 and a beta of 1.11. The business has a 50 day moving average of $59.40 and a 200-day moving average of $54.92. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. The company had revenue of $661.60 million during the quarter, compared to analysts’ expectations of $672.07 million. As a group, equities research analysts forecast that Stericycle, Inc. will post 2.29 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SRCL has been the topic of several recent research reports. Truist Financial lifted their price target on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. StockNews.com assumed coverage on Stericycle in a research note on Tuesday, September 17th. They issued a “hold” rating on the stock. Royal Bank of Canada restated a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods raised their price objective on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.